Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2024-01-09

FDA Approved: FLUOROMETHOLONE OPHTHALMIC SUSPENSION — Original Application (Amneal Pharmaceuticals NY LLC)

View source ↗

Summary

FDA approved Amneal Pharmaceuticals NY LLC’s fluorometholone ophthalmic suspension under an Original Application (ANDA216348).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Fluorometholone Ophthalmic Suspension (Fluorometholone)

Snippet

ORIG AP for FLUOROMETHOLONE OPHTHALMIC SUSPENSION (FLUOROMETHOLONE)